UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REACTIVE T CELLS FOR TREATMENT OF CANCER

Research output: Other contribution

2 Downloads (Pure)

Original language	Undefined/Unknown
State	Published - Feb 7 2023

Name	Technology Transfer - Patents

Access to Document

@misc{3c48842e3bae4fb78dfea5f7848120f9,

title = "UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REACTIVE T CELLS FOR TREATMENT OF CANCER",

author = "Weinberg, \{Andrew D\} and Ryan Montier and Thomas Duhen and Rebekka Duhen",

year = "2023",

month = feb,

day = "7",

language = "Undefined/Unknown",

series = "Technology Transfer - Patents",

type = "Other",

}